神経内科外来シリーズ 5 脳卒中外来

出版社: メジカルビュー社
著者:
発行日: 2017-02-10
分野: 臨床医学:内科  >  脳神経科学/神経内科学
ISBN: 9784758303866
シリーズ: 神経内科外来シリーズ
電子書籍版: 2017-02-10 (第1版第1刷)
書籍・雑誌
≪全国送料無料でお届け≫
取寄せ目安:8~14営業日

8,800 円(税込)

電子書籍
章別単位での購入はできません
ブラウザ、アプリ閲覧

8,800 円(税込)

商品紹介

本シリーズは特に患者の多い神経疾患(頭痛、認知症、パーキンソン病、てんかん、脳卒中)で構成。神経内科医が接する機会の多いこれらの疾患の外来診察に必要なノウハウを、シェーマ、フローチャートなどを多用しコンパクトにまとめて解説している。本書では「脳卒中」を取り上げる。脳卒中の患者数は150万人ともいわれ、日本人の死因の第3位となっている。I・II章では脳卒中の基本的知識、診察・治療の流れを解説。III章では脳卒中に含まれる各疾患を取り上げ、その診断から治療までを解説する。最後にCase Studyをとおしてその実際を学べるようにしている。脳卒中の診療に必要な知識を網羅した1冊である。

目次

  • 神経内科外来シリーズ 5 脳卒中外来

    ―目次―

    I 脳卒中についての基礎知識
     脳血管障害の分類
     脳卒中の疫学
     脳卒中の危険因子
     脳卒中の画像診断

    II 外来の基本的な流れ
     診察・診断の基本
     鑑別診断
     検査
     薬物療法
     外科治療の適応

    III 主な脳卒中の診断と治療
     アテローム血栓性脳梗塞
     ラクナ梗塞
     心原性脳塞栓症
     Branch atheromatous disease(BAD)
     一過性脳虚血発作
     悪性腫瘍に伴う脳梗塞(Trousseau症候群)
     脳出血
     くも膜下出血
     脳動静脈奇形、海綿状血管腫、静脈性血管腫
     脳動脈解離
     もやもや病
     遺伝性脳卒中
     脳静脈洞血栓症
     脳血管性認知症
     脳卒中後のてんかん
     脳血管性パーキンソニズム

    IV 脳卒中の最近のトピックス
     脳卒中治療ガイドライン2015の変更のポイン
     脳微小出血(microbleeds)
     Cerebral small vessel disease
     未破裂脳動脈瘤

    V 社会資源の活用法
     介護保険制度、身体障害者福祉法による認定
     日本脳卒中協会

    VI Case study
     アテローム血栓性脳梗塞
     心原性脳塞栓症
     ラクナ梗塞
     頸動脈病変に対してステント留置(CAS)した症例

この書籍の参考文献

参考文献のリンクは、リンク先の都合等により正しく表示されない場合がありますので、あらかじめご了承下さい。

本参考文献は電子書籍掲載内容を元にしております。

I 脳卒中についての基礎知識

P.10 掲載の参考文献
1) Special report from the National Institute of Neurological Disorders and Stroke. Classification of cerebrovascular diseases III. Stroke 1990 ; 21 : 637-76.
2) Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 1993 ; 24 : 35-41.
3) A Classification and Outline of Cerebrovascular Diseases II. Stroke 1975 ; 6 : 564-616.
4) Ay H, Benner T, et al. A computerized algorithm for etiologic classification of ischemic stroke. The Causative Classification of Stroke System. Stroke 2007 ; 38 : 2979-84.
5) Amarenco P, Bogousslavsky J, et al. New approach to stroke subtyping : the A-S-C-O (phenotypic) classification of stroke. Cerebrovasc Dis 2009 ; 27 : 502-8.
6) Easton JD, Saver JL, et al. Definition and evaluation of transient ischemic attack : A scientific statement for healthcare professionals from the American Heart Association/American Stroke Association Stroke Council. Stroke 2009 ; 40 : 2276-93.
7) Kernan WN, Ovbiagele B, et al. Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack : A guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2014 ; 45 : 2160-236.
8) Caplan LR. Intracranial branch atheromatous disease : a neglected, understudied, and underused concept. Neurology 1989 ; 39 : 1246-50.
9) Hart RG, Diener HC, et al. Embolic strokes of undetermined source : the case for a new clinical construct. Lancet Neurol 2014 ; 113 : 429-38.
P.19 掲載の参考文献
1) 厚生労働省大臣官房統計情報部 : 〔主な死因〕脳血管疾患. 平成26年 人口動態統計 上巻, 厚生労働統計協会, 2016, p372-3.
2) Hata J, Ninomiya T, et al. Secular trends in cardiovascular disease and its risk factors in Japanese : Half-century data from the Hisayama Study (1961-2009). Circulation 2013 ; 128 : 1198-205.
3) 鈴木一夫. 日本の脳卒中の特徴. 老年病予防 2002 ; 1 : 16-22.
4) Kubo M, Hata J, Doi Y, et al. Secular trends in the incidence of and risk factors for ischemic stroke and its subtypes in Japanese population. Circulation 2008 ; 118 : 2672-8.
5) Hata J, Tanizaki Y, et al. Ten year recurrence after first ever stroke in a Japanese community : the Hisayama study. J Neurol Neurosurg Psychiatry 2005 ; 76 : 368-72.
6) OECD (2013). Mortality from cardiovascular diseases. Health at a Glance. 2013 : OECD Indicators, OECD Publishing, 2013, p28-9.
7) Feigin VL, Forouzanfar MH, et al. Global and regional burden of stroke during 1990-2010 : findings from the Global Burden of Disease Study 2010. Lancet 2014 ; 383 : 245-55.
P.26 掲載の参考文献
1) Meschia JF, Bushnell C, Boden-Albala B, et al. Guidelines for the primary prevention of stroke : a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2014 ; 45 : 3754-832.
2) Asplund K, Karvanen J, Giampaoli S, et al. Relative risks for stroke by age, sex, and population based on follow-up of 18 European populations in the MORGAM Project. Stroke 2009 ; 40 : 2319-26.
3) Thompson BG, Brown RD Jr, Amin-Hanjani S, et al. Guidelines for the Management of Patients With Unruptured Intracranial Aneurysms : A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke 2015 ; 46 : 2368-400.
4) 日本高血圧学会高血圧治療ガイドライン作成委員会. 高血圧治療ガイドライン 2014. ライフサイエンス出版, 東京, 2014.
5) 日本脳卒中学会 脳卒中ガイドライン委員会編. 脳卒中治療ガイドライン 2015. 協和企画, 東京, 2015.
6) 日本動脈硬化学会. 動脈硬化性疾患予防ガイドライン 2012年版. 杏林舎, 東京, 2012.
7) Writing C, Lloyd-Jones DM, Morris PB, et al. 2016 ACC Expert Consensus Decision Pathway on the Role of Non-Statin Therapies for LDL-Cholesterol Lowering in the Management of Atherosclerotic Cardiovascular Disease Risk : A Report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents. J Am Coll Cardiol 2016 ; 68 : 92-125.
8) Goldstein LB, Bushnell CD, Adams RJ, et al. Guidelines for the primary prevention of stroke : a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2011 ; 42 : 517-84.
9) Shinton R, Beevers G. Meta-analysis of relation between cigarette smoking and stroke. BMJ 1989 ; 298 : 789-94.
10) Eckel RH, Jakicic JM, Ard JD, et al. 2013 AHA/ACC guideline on lifestyle management to reduce cardiovascular risk : a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 2014 ; 129 : S76-99.
P.38 掲載の参考文献
1) Uchino A, Saito N, et al. Variations in the origin of the vertebral artery and its level of entry into the transverse foramen diagnosed by CT angiography. Neuroradiology 2013 ; 55 : 585-94.
2) Uchino A, Saito N, et al. Variation of the origin of the left common carotid artery diagnosed by CT angiography. Surg Radiol Anat 2013 ; 35 : 339-42.
3) Nagahata M, Abe Y, et al. Surface appearance of the vertebrobasilar artery revealed on basiparallel anatomic scanning (BPAS) -MR imaging : its role for brain MR examination. AJNR Am J Neuroradiol 2005 ; 26 : 2508-13.
4) Kato Y, Dembo T, et al. Outer contour of middle cerebral artery revealed by sylvian vallecular-parallel anatomic scanning-magnetic resonance imaging : a method useful for detecting dissection. Arch Neurol 2010 ; 67 : 1278-9.
5) Maruyama H, Nagoya H, et al. Spontaneous cervicocephalic arterial dissection with headache and neck pain as the only symptom. J Headache Pain 2012 ; 13 : 247-53.
6) Deguchi I, Takeda H, et al. Significance of magnetic resonance angiography-diffusion weighted imaging mismatch in hyperacute cerebral infarction. J Stroke Cerebrovasc Dis 2012 ; 21 : 108-13.
7) Uchino A. Selective catheterization of the brachiocephalic arteries via the right brachial artery. Neuroradiology 1988 ; 30 : 524-7.

II 外来の基本的な流れ

P.45 掲載の参考文献
1) Kim JS. Symptoms of transient ischemic attack. In ; Uchiyama S, Amerenco P, Minematsu K, Wong KSL eds. TIA as Acute Cerebrovascular Syndrome. Karger, Basel, 2014.
2) Kravitz HL, Kravitz RL. Subtleties of Medical History Taking. In ; Tierney LM Jr, Henderson MC, eds. The Patient History. McGraw-Hill Education, New York, 2005.
3) von Arbin M, Britton M, DeFaire U, et al. Validation of admission criteria to a stroke unit. J Chronic Dis 1980 ; 33 : 215-20.
4) McGee S. Evidence-Based Physical Diagnosis. Elsevier, Philadelphia, 2012.
5) Sanna T, Diener HC, Passman RS, et al. Cryptogenic stroke and underlying atrial fibrillation. N Engl J Med 2014 ; 370 : 2478-86.
6) McFadden JP, Price RC, Eastwood HD, et al. Raised respiratory rate in elderly patients : a valuable physical sign. Br Med J (Clin Res Ed) 1982 ; 284 : 626-7.
7) Kerber KA, Brown DL, Lisabeth LD, et al. Stroke among patients with dizziness, vertigo, and imbalance in the emergency department : a population-based study. Stroke 2006 ; 37 : 2484-7.
8) Kattah JC, Talkad AV, Wang DZ, et al. HINTS to diagnose stroke in the acute vestibular syndrome : three-step bedside oculomotor examination more sensitive than early MRI diffusion-weighted imaging. Stroke 2009 ; 40 : 3504-10.
9) Panzer RJ, Feibel JH, Barker WH, et al. Predicting the likelihood of hemorrhage in patients with stroke. Arch Intern Med 1985 ; 145 : 1800-3.
P.56 掲載の参考文献
1) Hand PJ, Kwan J, Lindley RI, et al. Distinguishing between stroke and mimic at the bedside : the brain attack study. Stroke 2006 ; 37 (3) : 769-75.
2) 野川茂. 脳梗塞に対するt-PA静注療法の使い方と問題点. Medical Practice 2008 ; 25 : 2245-52.
3) Kreppel D, Antoniadis G, Seeling W. Spinal hematoma : a literature survey with meta-analysis of 613 patients. Neurosurg Rev 2003 ; 26 (1) : 1-49.
4) Gaul C, Dietrich W, Friedrich I, et al. Neurological symptoms in type A aortic dissections. Stroke 2007 ; 38 (2) : 292-7.
5) Flemming KD, Brown RD Jr. Acute cerebral infarction caused by aortic dissection : caution in the thrombolytic era. Stroke 1999 ; 30 (2) : 477-8.
6) Lopez JA, Ross RS, Fishbein MC, et al. Nonbacterial thrombotic endocarditis : a review. Am Heart J 1987 ; 113 (3) : 773-84.
7) Chen Y, Zeng J, Xie X, et al. Clinical features of systemic cancer patients with acute cerebral infarction and its underlying pathogenesis. Int J Clin Exp Med 2015 ; 8 (3) : 4455-63.
8) 野川茂. がんと脳梗塞-トルーソー症候群の臨床. 血栓止血誌 2016 ; 27 : 18-28.
9) Subramaniam S, Puetz V, Dzialowski I, et al. Cerebral microhemorrhages in a patient with mycotic aneurysm : relevance of T2-GRE imaging in SBE. Neurology 2006 ; 67 (9) : 1697.
10) Fujiwara H, Momoshima S, Kuribayashi S. Leptomeningeal high signal intensity (ivy sign) on fluid-attenuated inversion-recovery (FLAIR) MR images in moyamoya disease. Eur J Radiol 2005 ; 55 (2) : 224-30.
P.63 掲載の参考文献
1) Jauch EC, Saver JL, Adams HP Jr, et al. Guidelines for the early management of patients with acute ischemic stroke : a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2013 ; 44 : 870-947.
2) 松林公蔵, 小沢利男. 心脳卒中. 現代医療 1987 ; 19 : 174-8.
3) 日本脳卒中学会. お知らせ文書「大動脈解離, 大動脈瘤とアルテプラーゼについて」. 平成19年8月 (http://www.jsts.gr.jp/)
4) Wardlaw JM, Mielke O. Early signs of brain infarction at CT : observer reliability and outcome after thrombolytic treatment-systematic review. Radiology 2005 ; 235 : 444-53.
5) 急性期脳梗塞画像診断実践ガイドライン 2007, 南江堂, 東京, 2007, p3-6.
6) Mullins ME, Schaefer PW, et al. CT and conventional and diffusion-weighted MR imaging in acute stroke : study in 691 patients at presentation to the emergency department. Radiology 2002 ; 224 : 353-60.
P.72 掲載の参考文献
1) 日本脳卒中学会脳卒中ガイドライン委員会編. 脳卒中治療ガイドライン 2015, 協和企画, 東京, 2015, p54-220.
2) Liu Y, Fei Z, et al. Efficacy and safety of short-term dualversus mono-antiplatelet therapy in patients with ischemic stroke or TIA : a meta-analysis of 10 randomized controlled trials. J Neurol 2016 263 : 2247-59.
3) Canhao P. Transient ischemic attacks (TIAs) -an underrecognized and undetreated disorder. In ; Biller J, Ferro J, Eds. Common pitfalls in cerebrovasuclar disease, Cambridge, 2015, p27-38.
4) Heidbuchel H, Verhamme P, et al. European Heart Rhythm Association Practical Guide on the use of new oral anticoagulants in patients with non-valvular atrial fibrillation. Europace 2013 ; 15 : 625-51.
5) Kirchhof P, Benussi S, et al. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur J Cardiothorac Surg 2016 ; 50 : e1-e88. [Epub 2016 Sep 23]
6) Hankey GJ. Intracranial hemorrhage and novel anticoagulants for atrial fibrillation : what have we learned? Curr Cardiol Rep 2014 ; 16 : 480.
7) Pisters R, Lane DA, et al. A novel user-friendly score (HASBLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation : the Euro Heart Survey. Chest 2010 ; 138 : 1093-100.
8) Gage BF, Waterman AD, et al. Validation of clinical classification schemes for predicting stroke : results from the National Registry of Atrial Fibrillation. JAMA 2001 ; 285 : 2864-70.
9) Wilson D, Jager HR, et al. Anticoagulation for Atrial Fibrillation in Patients with Cerebral Microbleeds. Curr Atheroscler Rep 2015 ; 17 : 47.
10) 市川智英, 渡邉英一. 抗凝固療法ブラッシュアップ. 抜歯, 内視鏡, 外科手術時の対応. 月刊薬事 2015 ; 57 : 1059-62.
11) 藤本一眞, 藤城光弘, 他. 抗血栓薬服用者に対する消化器内視鏡診療ガイドライン. Gastroenterol Endosc 2012 ; 54 : 2075-102.
12) Douketis JD, Spyropoulos AC, et al. Perioperative Bridging Anticoagulation in Patients with Atrial Fibrillation. New Engl J Med 2015 ; 373 : 823-33.
P.83 掲載の参考文献
1) JET Study Group. Japanese EC-IC Bypass Trial (JET Study) 中間解析報告 (第二報). 脳卒中の外科 2002 ; 30 : 434-7.
2) 日本脳卒中学会 脳卒中ガイドライン委員会編. 脳卒中治療ガイドライン 2015, 協和企画, 東京, 2015.
3) Yadav JS, Wholey MH, Kuntz RE, et al. Protected carotidartery stenting versus endarterectomy in high-risk patients. N Engl J Med 2004 ; 351 : 1493-501.
4) The UCAS Japan Investigators. The natural course of unruptured cerebral aneurysms in a Japanese cohort. N Engl J Med 2012 ; 366 : 2474-82.
5) Miyamoto S. Study design for a prospective randomized trial of extracranial-intracranial bypass surgery for adults with Moyamoya disease and hemorrhagic onset-the Japan Adult Moyamoya Trial Group. Neurol Med Chir (Tokyo) 2004 ; 44 : 218-9.

III 主な脳卒中の診断と治療

P.95 掲載の参考文献
1) Ueno Y, Kimura K, et al. Mobile aortic plaques are a cause of multiple brain infarcts seen on diffusion-weighted imaging. Stroke 2007 ; 38 : 2470-76.
2) Wang Y, Wang Y, et al. Clopidogrel with aspirin in acute minor stroke or transient ischemic attack. N Engl J Med 2013 ; 369 : 11-9.
3) Markus HS, Droste DW, et al. Dual antiplatelet therapy with clopidogrel and aspirin in symptomatic carotid stenosis evaluated using doppler embolic signal detection : the Clopidogrel and Aspirin for Reduction of Emboli in Symptomatic Carotid Stenosis (CARESS) trial. Circulation 2005 ; 111 : 2233-40.
4) Wong KS, Chen C, et al. Clopidogrel plus aspirin versus aspirin alone for reducing embolisation in patients with acute symptomatic cerebral or carotid artery stenosis (CLAIR study) : a randomised, open-label, blinded-endpoint trial. Lancet Neurol 2010 ; 9 : 489-97.
5) Toyoda K, Yasaka M, et al. Blood pressure levels and bleeding events during antithrombotic therapy : the Bleeding with Antithrombotic Therapy (BAT) Study. Stroke 2010 ; 41 : 1440-4.
6) Hosomi N, Nagai Y, et al. The Japan Statin Treatment Against Recurrent Stroke (J-STARS) : A Multicenter, Randomized, Open-label, Parallel-group Study. EBioMedicine 2015 ; 2 : 1071-8.
7) Ueno Y, Yamashiro K, et al. Rosuvastatin may stabilize atherosclerotic aortic plaque : Transesophageal echocardiographic study in the EPISTEME trial. Atherosclerosis 2015 ; 239 : 476-82.
8) Urabe T, Watada H, et al. Prevalence of abnormal glucose metabolism and insulin resistance among subtypes of ischemic stroke in Japanese patients. Stroke 2009 ; 40 : 1289-95.
9) Wilcox R, Bousser MG, et al. Effects of pioglitazone in patients with type 2 diabetes with or without previous stroke. Results from PROactive (PROspective pioglitAzone Clinical Trial In macroVascular Events 04). Stroke 2007 ; 38 : 865-73.
P.104 掲載の参考文献
1) Fisher CM. Lacunar strokes and infarcts : a review. Neurology 1982 ; 32 : 871-6.
2) 小林祥泰編. 脳卒中データバンク 2015, 中山書店, 東京, 2015.
3) Wardlaw JM, Smith C, Dichgans M. Mechanisms of sporadic cerebral small vessel disease : insights from neuroimaging. Lancet Neurol 2013 ; 12 : 483-97.
4) 冨本秀和. 脳小血管病の概念と分類. 脳卒中 2013 ; 35 : 128-32.
5) Bezerra DC, Sharrett AR, Matsushita K, et al. Risk factors for lacune subtypes in the Atherosclerosis Risk in Communities (ARIC) Study. Neurology 2012 ; 78 : 102-8.
6) Macdonald RL, Kowalczuk A, Johns L. Emboli enter penetrating arteries of monkey brain in relation to their size. Stroke 1995 ; 26 : 1247-50 ; discussion 1250-1.
7) Mohr JP, Kase CS, Meckler RJ, et al. Sensorimotor stroke due to thalamocapsular ischemia. Arch Neurol 1977 ; 34 : 739-41.
8) Gan R, Sacco RL, Kargman DE, et al. Testing the validity of the lacunar hypothesis : the Northern Manhattan Stroke Study experience. Neurology 1997 ; 48 : 1204-11.
9) Steinke W, Ley SC. Lacunar stroke is the major cause of progressive motor deficits. Stroke 2002 ; 33 : 1510-6.
10) Lammie GA, Brannan F, Slattery J, et al. Nonhypertensive cerebral small-vessel disease. An autopsy study. Stroke 1997 ; 28 : 2222-9.
11) Woo D, Gebel J, Miller R, et al. Incidence rates of first-ever ischemic stroke subtypes among blacks : a population-based study. Stroke 1999 ; 30 : 2517-22.
12) Chamorro A, Sacco RL, Mohr JP, et al. Clinical-computed tomographic correlations of lacunar infarction in the Stroke Data Bank. Stroke 1991 ; 22 : 175-81.
13) van Dijk EJ, Prins ND, Vermeer SE, et al. Plasma amyloid beta, apolipoprotein E, lacunar infarcts, and white matter lesions. Ann Neurol 2004 ; 55 : 570-5.
14) Yonemura K, Kimura K, Minematsu K, et al. Small centrum ovale infarcts on diffusion-weighted magnetic resonance imaging. Stroke 2002 ; 33 : 1541-4.
15) Charidimou A, Kakar P, Fox Z, et al. Cerebral microbleeds and recurrent stroke risk : systematic review and metaanalysis of prospective ischemic stroke and transient ischemic attack cohorts. Stroke 2013 ; 44 : 995-1001.
P.115 掲載の参考文献
2) 小林祥泰編. 脳卒中データバンク 2015, 中山書店, 東京, 2015, p18-9.
3) Wolf PA, et al. Atrial fibrillation as an independent risk factor for stroke : The Framingham study. Stroke 1991 : 22 : 983-8.
4) 小林祥泰編. 脳卒中データバンク 2015, 中山書店, 東京, 2015, p62-3.
5) Sanossian N, et al. Angiography reveals that fluid-attenuated inversion recovery vascular hyperintensities are due to slow flow, not thrombus. AJNR Am J Neuroradiol 2009 ; 30 : 564-8.
6) Cho KH, et al. Significance of susceptibility vessel sign on T2*-weighted gradient echo imaging for identification of stroke subtypes. Stroke 2005 ; 36 : 2379-83.
7) Kawano H, et al. Modified ASPECTS for DWI including deep white matter lesions predicts subsequent intracranial hemorrhage. J Neurol 2012 ; 259 : 2045-52.
8) Nezu, et al. Pretreatment ASPECTS on DWI predicts 3-month outcome following rt-PA : SAMURAI rt-PA Registry. Neurology 2010 ; 75 : 555-61.
9) Di Tullio MR, et al. Patent foramen ovale and the risk of ischemic stroke in a multiethnic population. Am J Coll Cardiol 2007 ; 49 : 797-802.
10) 日本脳卒中学会 脳卒中医療向上・社会保険委員会 rt-PA (アルテプラーゼ) 静注療法指針改定部会. rt-PA (アルテプラーゼ) 静注療法 適正治療指針 第二版, 2012 (2016一部改訂), p20-1.
11) Goyal M, et al. Endovascular thrombectomy after largevessel ischaemic stroke : a meta-analysis of individual patient data from five randomised trials. Lancet 2016 ; 387 : 1723-31.
12) 日本脳卒中学会, 日本脳神経外科学会, 日本脳神経血管内治療学会. 経皮経管的脳血管回収用機器 適応使用指針 第2版. 脳卒中 2015 ; 37 : 259-79.
13) Powers WJ, et al. 2015 American Heart Association/American Stroke Association Focused Update of the 2013 Guidelines for the Early Management of Patients With Acute Ischemic Stroke Regarding Endovascular Treatment. Stroke 2015 ; 46 : 3020-35.
14) Gage BF, et al. Validation of clinical classification schemes for predicting stroke : results from the National Registry of Atrial Fibrillation. JAMA 2001 ; 285 : 2864-70.
15) 日本脳卒中学会 脳卒中ガイドライン委員会編. 脳卒中治療ガイドライン 2015, 協和企画, 東京, 2015, p115.
16) Toyoda K, et al. Trends in oral anticoagulant choice for acute stroke patients with nonvalvular atrial fibrillation in Japan : the SAMURAI-NVAF study. Int J Stroke 2015 ; 10 : 836-42.
17) Chimowitz MI, et al. Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis. N Engl J Med 2005 ; 352 : 1305-16.
P.125 掲載の参考文献
1) Caplan CR. Intracranial branch atheromatous disease : A neglected, understudied, and underused concept. Neurology 2004 ; 39 : 1246-50.
2) 星野晴彦, 高木誠, 他. Branch atheromatous diseaseにおける進行性脳梗塞と急性期転帰. 脳卒中 2011 ; 33 : 37-44.
3) 高木誠. Branch atheromatous diseaseの概念. 神経内科 2008 ; 69 : 542-9.
4) Adams HP, Bendixen BH, et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. Stroke 1993 ; 24 : 35-41.
5) Cho ZH, Kang CK, et al. Observation of the lenticulostriate arteries in the human brain in vivo using 7.0T MR angiography. Stroke 2008 ; 39 : 1604-6.
6) 温井孝昌, 星野晴彦, 他. 3カ月間に脳虚血発作を7回繰り返し脳梗塞に至ったbranch atheromatous diseaseの1例. 脳卒中 2016 ; 38 : 256-61.
7) Yamada M, Yoshimura S, et al. Prediction of neurologic deterioration in patients with lacunar infarction in the territory of the lenticulostriate artery using perfusion CT. AJNR Am J Neuroragiol 2004 ; 25 : 402-8.
8) Yamamoto Y, Ohara T, et al. A combined treatment for acute larger lacunar-type infarction. J Stroke Cerebrovasc Dis 2011 ; 20 : 387-94.
9) Suto Y, Nakayasu H, et al. Long-term prognosis with large subcortical infarctions. Eur Neurol 2009 ; 62 : 304-10.
P.134 掲載の参考文献
1) Chandratheva A, Mehta Z, et al. Population-based study of risk and predictors of stroke in the first few hours after a TIA. Neurology 2009 ; 72 : 1941-7.
2) Easton JD, Saver JL, et al. Definition and evaluation of transient ischemic attack. A scientific statement for healthcare professionals from the American Heart Association/American Stroke Association Stroke Council ; Council on Cardiovascular surgery and Anesthesia ; Council on Cardiovascular Radiology and Intervention ; Council on Cardiovascular Nursing ; and the Interdisciplinary Council on Peripheral Vascular Disease. Stroke 2009 ; 40 : 2276-93.
3) Special report from the National Institute of Neurological Disorders and Stroke. Classification of cerebrovascular diseases III. Stroke 1990 ; 21 : 637-76.
4) 上原敏志, 峰松一夫. 定義. TIA診療マニュアル. 平成21-23年度厚生労働科学研究費補助金による「TIAの診断基準の再検討, ならびにわが国の医療環境に則した適切な診断・治療システムの確立に関する研究」班 (主任研究者 : 峰松一夫), 大阪, 2012, 11-3.
5) Kimura K, Kazui S, et al. Analysis of 16,922 patients with acute ischemic stroke and transient ischemic attack in Japan. A hospital-based prospective registration study. Cerebrovasc Dis 2004 ; 18 : 47-56.
6) 長谷川泰弘. TNA (一過性神経発作) とTIAはいかに対応すべきか. Medicina 2013 ; 50 : 210-3.
7) Donnan GA, O'Malley HM, et al. The capsular warning syndrome : pathogenesis and clinical features. Neurology 1993 ; 43 : 957-62.
8) Johnston SC, Rothwell PM, et al. Validation and refinement of scores to predict very early stroke risk after transient ischaemic attack. Lancet 2007 ; 369 : 283-92.
9) 日本脳卒中学会脳卒中ガイドライン 編. TIAの急性期治療と再発予防. 脳卒中治療ガイドライン 2015, 協和企画, 東京, 2015, p81-7.
10) Wang Y, Johnston SC, et al. Clopidogrel with aspirin in acute minor stroke or transient ischemic attack. N Eng J Med 2013 ; 369 : 11-9.
P.145 掲載の参考文献
1) 高橋愼一, 大木宏一, 他. 癌と脳卒中. 脳卒中 2015 ; 37 : 395-402.
2) Varki A. Trousseau's syndrome : multiple definitions and multiple mechanisms. Blood 2007 ; 110 : 1723-9.
3) Graus F, Rogers LR, et al. Cerebrovascular complications in patients with cancer. Medicine (Baltimore) 1985 ; 64 : 16-35.
4) Sack GH, Levin J, et al. Trousseau's syndrome and other manifestations of chronic disseminated coagulopathy in patients with neoplasms : clinical, pathophysiologic, and therapeutic features. Medicine (Baltimore) 1977 ; 56 : 1-37.
5) Cestari DM, Weine DM, et al. Stroke in patients with cancer : incidence and etiology. Neurology 2004 ; 62 : 2025-30.
6) Gross L, Friedberg CK. Nonbacterial thrombotic endocarditis. Classification and general description. Arch Intern Med 1936 ; 58 : 620-40.
7) Asopa S, Patel A, et al. Non-bacterial thrombotic endocarditis. Eur J Cardiothorac Surg 2007 ; 32 : 696-701.
8) Kim SJ, Park JH, et al. Clues to occult cancer in patients with ischemic stroke. PLoS One 2012 ; 7 (9) : e44959. doi : 10.1371/journal.pone.0044959.
9) 伊澤良兼, 傳法倫久, 他. 悪性腫瘍患者に合併した脳梗塞に対する治療の検討. 日内会誌 2009 ; 98 (suppl) : 155.
10) Yagi T, Takahashi K, et al. Fatal intracranial hemorrhage after intravenous thrombolytic therapy for acute ischemic stroke associated with cancer-related nonbacterial thrombotic endocarditis. J Stroke Cerebrovasc Dis 2014 ; 23 (8) : e413-6.
P.153 掲載の参考文献
1) 日本脳卒中学会 脳卒中ガイドライン委員会編. 脳卒中治療ガイドライン 2015, 協和企画, 東京, 2015.
2) 高橋昭喜 編著. 脳MRI 3. 血管障害・腫瘍・感染症・他, 秀潤社, 東京, 2010, p100.
3) Anderson CS, Heeley E, et al. Rapid blood-pressure lowering in patients with acute intracerebral hemorrhage. N Engl J Med 2013 ; 368 : 2355-65.
4) Koga M, Arihiro S, et al. Intravenous nicardipine dosing for blood pressure lowering in acute intracerebral hemorrhage : the Stroke Acute Management with Urgent Risk-factor Assessment and Improvement-Intracerebral Hemorrhage study. J Stroke Cerebrovasc Dis 2014 ; 23 : 2780-7.
5) Mendelow AD, Gregson BA, et al. Early surgery versus initial conservative treatment in patients with spontaneous supratentorial intracerebral haematomas in the International Surgical Trial in Intracerebral Haemorrhage (STICH) : a randomised trial. Lancet 2005 ; 365 : 387-97.
6) Mendelow AD, Gregson BA, et al. Early surgery versus initial conservative treatment in patients with spontaneous supratentorial lobar intracerebral haematomas (STICH II) : a randomised trial. Lancet 2013 ; 382 : 397-408.
7) Gregson BA, Broderick JP, et al. Individual patient data subgroup meta-analysis of surgery for spontaneous supratentorial intracerebral hemorrhage. Stroke 2012 ; 43 : 1496-504.
8) Hattori N, Katayama Y, et al. Impact of stereotactic hematoma evacuation on activities of daily living during the chronic period following spontaneous putaminal hemorrhage : a randomized study. J Neurosurg 2004 ; 101 : 417-20.
P.163 掲載の参考文献
1) Kowalski RG, Claassen J, et al. Initial Misdiagnosis and Outcome After Subarachnoid Hemorrhage. JAMA 2004 ; 291 : 866-9.
2) Rinkel GJE, Algra A. Long-term outcomes of patients with aneurysmal subarachnoid haemorrhage. The Lancet Neurology 2011 ; 10 : 349-56.
3) Edlow JA, Caplan LR. Avoiding pitfalls in the diagnosis of subarachnoid hemorrhage. N Engl J Med 2000 ; 342 : 29-36.
4) Schievink WI, Karemaker JM, et al. Circumstances surrounding aneurysmal subarachnoid hemorrhage. Surg Neurol 1989 ; 32 : 266-72.
5) Perry JJ, Stiell IG, et al. Clinical decision rules to rule out subarachnoid hemorrhage for acute headache. JAMA 2013 ; 310 : 1248-55.
6) Perry JJ, Stiell IG, et al. Sensitivity of computed tomography performed within six hours of onset of headache for diagnosis of subarachnoid haemorrhage : prospective cohort study. BMJ 2011 ; 343 : d4277-7.
7) Mohamed M, Heasly DC, et al. Fluid-attenuated inversion recovery MR imaging and subarachnoid hemorrhage : not a panacea. AJNR Am J Neuroradiol 2004 ; 25 : 545-50.
8) Perry JJ, Alyahya B, et al. Differentiation between traumatic tap and aneurysmal subarachnoid hemorrhage : prospective cohort study. BMJ 2015 ; 350 : h568-8.
P.174 掲載の参考文献
1) Yasargil M. Pathological consideration. Microneurosurgery IIIA. Georg Thieme Verlagm Thieme Medical Publishers, Inc. Stuttgart- New York, 1987, p49-211.
2) 田中美千裕. 動静脈シャントの構造と血管構築. angioarchitecture of the arteriovenous shunts. 脳脊髄血管-正常から変異, 異常まで, メディカ出版, 大阪, 2014, p202-13.
3) Lasjaunias PL, Landrieu P, et al. Cerebral proliferative angiopathy clinical and angiographical description of an entity different from cerebral AVM. Stroke 2008 ; 39 : 878-85.
4) Morfenstern PE, Hoffman CE, et al. Postoperative imaging for detection of recurrent arteriovenous malformations in children. J Neurosurg Pediatrics 2015 ; 30 : 1-7.
5) Tong X, Wu J, et al. The effect of age, sex, and lesion location on initial presentation in patients with brain arteriovenous malformations. World Neurosurg 2016 : 87 ; 598-606.
6) Perret G, Nishioka H. Report on the Cooperative Study of Intracranial Aneurysm and subarchnoid hemorrhage, Arteriovenous Malformations. J Neurosurg 1966 : 25 : 467-90.
7) Morgan M, Sekhon L, et al. Morbidity of intracranial hemorrhage in patients with cerebral arteriovenous malformation. Stroke 1998 ; 29 : 2001-2.
8) Yamane F, Takeshita M, et al. Natural history of arteriovenous malformations analysis of non-radically treated patients. J Clin Neurosci 1998 ; 5 Suppl : 26-9.
10) Spetzler RF, Martin NA, et al. Surgical management of large AVM's by staged embolization and operative excision. J Neurosurg 1987 ; 67 : 17-28.
11) Mendes GA, Slveira EP, et al. Endovascular management of deep artreriovenous malformations. Single Institutional experiences. Neurosurgery 2016 : 78 : 34-41.
12) Natarajan SK, Ghodke B, et al. Multimodality treatment of brain arteriomalformations with microsurgery after embolization with onyx : single-center experience and technical nuances. Neurosurgery 2008 ; 62 : 1213-26.
13) Mohr JP, Parides MK, et al. Medical management with or without interventional therapy for unruptured brain arteriovenous malformations (ARUBA) : a multicenter, nonblinded, randomised trial. Lancet 2014 ; 383 : 614-21.
14) Schramm J, Schaller K, et al. Microsurgery for cerebral arteriovenous malformations : subgroup outcomes in a consecutive series of 288 cases. J Neurosurg 2016 ; 10 : 1-8 Epub.
15) Ding D, Starke RM, et al. Radiosurgery for cerebral arteriovenous malforomations in a randomized trial of unruptures brain arteriovenous malformations (ARUBA) Eligible patients : A multicenter Study. Stroke 2016 ; 47 : 342-9.
16) Magro E, Gentric JC, et al. Responses to ARUBA : a systematic review and critical analysis for the design of future arteriovenous malformation trials. J Neurosurg 2016 ; 29 : 1-9. [Epub ahead of print]
17) Gross BA, Du R. Hemorrhage from cerebral cavernous malformations : a systematic pooled analysis. J Neurosurg 2016 ; 20 : 1-9. [Epub ahead of print]
18) Garner TB, Del Curling O, et al. The natural history of intracranial venous angiomas. J Neurosurg 1991 ; 75 : 715-22.
19) McLaughlin MR, Kondziolka D, et al. The prospective natural history of cerebral venous malformations. Neurosurgery 1998 ; 43 : 195-200.
20) Aoki R, Srivatanakul K. Developmental venous anomaly : benign or not benign. Neurol Med Chir (Tokyo) 2016 ; 56 : 534-43.
P.183 掲載の参考文献
1) Debette S, Leys D. Cervical-artery dissections : predisposing factors, diagnosis, and outcome. Lancet Neurol 2009 ; 8 : 668-78.
2) Putaala J, Metso AJ, et al. Analysis of 1008 consecutive patients aged 15 to 49 with first-ever ischemic stroke : the Helsinki young stroke registry. Stroke 2009 ; 40 : 1195-203.
3) 循環器病研究委託費 18 公-5 脳動脈解離診療の手引き」 (SCADS-Japan) (主任研究者 : 峰松一夫) 国立循環器病センター内科脳血管部門, 2009.
4) 小野純一, 樋口佳則, 他. 椎骨脳底動脈系頭蓋内動脈解離の全国調査 (最終報告) (第1報) 概要について. 脳卒中の外科 2015 ; 43 : 245-51.
5) Debette S, Compter A, et al. Epidemiology, pathophysiology, diagnosis, and management of intracranial artery dissection. Lancet Neurol 2015 ; 14 : 640-54.
6) Debette S, Kamatani Y, et al. Common variation in PHACTR1 is associated with susceptibility to cervical artery dissection. Nat Genet 2015 ; 47 : 78.
7) 山浦晶, 吉本高志, 他. 非外傷性頭蓋内解離性動脈病変の全国調査 (第一報). 脳卒中の外科 1998 ; 26 : 79-86.
8) CADISS trial investigators. Antiplatelet treatment compared with anticoagulation treatment for cervical artery dissection (CADISS) : a randomised trial. Lancet Neurol 2015 ; 14 : 361-7.
9) Mizutani T. Natural course of intracranial arterial dissections. J Neurosurg 2011 ; 114 : 1037-44.
10) Kato Y, Dembo T, et al. Outer contour of middle cerebral artery revealed by sylvian vallecula-parallel anatomic scanning-magnetic resonance imaging : a method useful for detecting dissection. Arch Neurol 2010 ; 67 : 1278-9.
11) 日本脳卒中学会 脳卒中ガイドライン委員会編. 脳卒中治療ガイドライン 2015, 協和企画, 東京, 2015.
P.191 掲載の参考文献
1) Wakai K, Tamakoshi A, Ikezaki, et al. Epidemiological features of moyamoya disease in Japan : findings from a nationwide survey. Clin Neurol Neurosurg 1997 ; 99 Suppl 2 : S1-5.
2) Baba T, Houkin K, Kuroda S. Novel epidemiological features of moyamoya disease. J Neurol Neurosurg Psychiatry 2008 ; 79 : 900-4.
3) Kuriyama S, Kusaka Y, Fujimura M, et al. Prevalence and clinicoepidemiological features of moyamoya disease in Japan : findings from a nationwide epidemiological survey. Stroke 2008 ; 39 : 42-7.
4) Liu W, Morito D, Takashima S, et al. Identification of RNF213 as a susceptibility gene for moyamoya disease and its possible role in vascular development. PLoS One 2011 ; 6 : e22542.
5) Kamada F, Aoki Y, Narisawa A, et al. A genome-wide association study identifies RNF213 as the first Moyamoya disease gene. J Hum Genet 2011 ; 56 : 34-40.
6) Miyatake S, Miyake N, Touho H, et al. Homozygous c.14576G>A variant of RNF213 predicts early-onset and severe form of moyamoya disease. Neurology 2012 ; 78 : 803-10.
7) Kuroda S, Hashimoto N, Yoshimoto T, et al. Radiological findings, clinical course, and outcome in asymptomatic moyamoya disease : results of multicenter survey in Japan. Stroke 2007 ; 38 : 1430-5.
8) 厚生労働科学研究費補助金難治性疾患克服事業ウイリス動脈輪閉塞症における病態・治療に関する研究班. もやもや病 (ウイリス動脈輪閉塞症) 診断・治療ガイドライン. 脳卒中の外科 2009 ; 37 : 321-37.
9) Suzuki J, Kodama N. Cerebrovascular "Moyamoya" disease. 2. Collateral routes to forebrain via ethmoid sinus and superior nasal meatus. Angiology 1971 ; 22 : 223-36.
10) Suzuki J, Takaku A. Cerebrovascular "moyamoya" disease. Disease showing abnormal net-like vessels in base of brain. Arch Neurol 1969 ; 20 : 288-99.
11) Miyamoto S, Yoshimoto T, Hashimoto N, et al. Effects of extracranial-intracranial bypass for patients with hemorrhagic moyamoya disease : results of the Japan Adult Moyamoya Trial. Stroke 2014 ; 45 : 1415-21.
12) 日本脳卒中学会 脳卒中ガイドライン委員会編. 脳卒中治療ガイドライン 2015, 協和企画, 東京, 2015.
13) 黒田敏, AMORE Study Group. 無症候性もやもや病の予後と治療法の確立をめざした多施設共同研究-AMORE. 研究について. 脳卒中の外科 2013 ; 41 : 235-39.
P.200 掲載の参考文献
1) Hademenos G, Alberts MJ, et al. Advances in the genetics of cerebrovascular disease and stroke. Neurology 2001 ; 56 : 997-1008.
2) Muqtadar H, Testai FD. Single gene disorders associated with stroke : a review and update on treatment options. Curr Treat Options Cardiovasc Med 2012 ; 14 : 288-97.
3) Tait RC, Walker ID, et al. Prevalence of protein C deficiency in the healthy population. Thromb Haemost 1995 ; 73 : 87-93.
4) Sakata T, Okamoto A, et al. Prevalence of protein S deficiency in the Japanese general population : the Suita Study. J Thromb Haemost 2004 ; 2 : 1012-3.
5) Cairns AG, North KN. Cerebrovascular dysplasia in neurofibromatosis type 1. J Neurol Neurosurg Psychiatry 2008 ; 79 : 1165-70.
6) Rombach SM, Dekker N, et al. Plasma globotriaosylsphingosine : diagnostic value and relation to clinical manifestations of Fabry disease. Biochim Biophys Acta 2010 ; 1802 : 741-8.
7) Rolfs A, Fazekas F, et al. Acute cerebrovascular disease in the young : the Stroke in Young Fabry Patients study. Stroke 2013 ; 44 : 340-9.
8) Yamada M. Cerebral amyloid angiopathy : an overview. Neuropathology 2000 ; 20 : 8-22.
9) Onda H, Kasuya H, et al. Genomewide-linkage and haplotype-association studies map intracranial aneurysm to chromosome 7q11. Am J Hum Genet 2001 ; 69 : 804-19.
P.212 掲載の参考文献
1) 後藤文男, 天野隆弘. 脳静脈・静脈洞. 臨床のための神経機能解剖学 (後藤文男, 天野隆弘編), 中外医学社, 東京, 1992, p122-3.
2) Einhaupl, KM, Masuhr F. Cerebral venous and sinus thrombosis-an update. Eur J Neurol 1994 ; 1 : 109-26.
3) Ameri A, Bousser MG. Cerebral venous thrombosis. Neurol Clin 1992 ; 10 : 87-111.
4) Kalbag RM. Cerebral venous thrombosis. In The cerebral venous system and its disorders (edited by Krapp JP & Schmidek HH), Grune & Stratton, Orlando, 1984, p505-36.
5) Villringer A, Mehraein S, et al. Pathophysiological aspects of cerebral sinus venous thrombosis (CSVT). J Neuroradiol 1994 ; 21 : 72-80.
6) Krayenbuhl HA. Cerebral venous and sinus thrombosis. Clin Neurosurg 1967 ; 14 : 1-24.
7) de Bruijn SFTM, et al. Clinical features and prognostic factors of cerebral venous sinus thrombosis in a prospective series of 59 patients. J Neurol Neurosurg Psychiatry 2001 ; 70 : 105-8.
8) Carroll JD, Leak D, et al. Cerebral thrombophlebitis in pregnancy and the puerperium. Q J Med 1966 ; 35 : 347-68.
9) Bansal BC, Gupta RR, et al. Stroke during pregnancy and pueruperium in young females below the age of 40 years as a result of cerebral venous/venous sinus thrombosis. Jpn Heart J 1980 ; 21 : 171-83.
10) Cantu C, Barinagarrementeria, F. Cerebral venous thrombosis associated with pregnancy and puerperium. Review of 67 cases. Stroke 1993 ; 24 : 1880-4.
11) Bousser MG. Cerebral venous thrombosis : diagnosis and management. J Neurol 2000 ; 247 : 252-8.
12) Hougie C. Thromboembolism and oral contraceptives. Am Heart J 1973 ; 85 : 538-45.
13) Poltera AA. The pathology of intracranial venous thrombosis in oral contraception. J Pathol 1972 ; 106 : 209-19.
14) Dindar F, Platts ME. Intracranial venous thrombosis complicating oral contraception. Can Med Assoc J 1974 ; 111 : 545-8.
15) Barnett HJM, Hyland HH. Non-infective intracranial venous thrombosis. Brain 1953 ; 76 : 36-49.
16) Averback, P. Primary cerebral venous thrombosis in young adults : the diverse manifestations of an underrecognized disease. Ann Neurol 1978 ; 3 : 81-6.
17) Lopez-Pelaez MF, Millan JM, et al. Fatal cerebral venous sinus thrombosis as major complication of metastatic cerebral mass : computed tomography and magnetic resonance findings. J Laryngol Otol 2000 ; 114 : 798-801.
18) Sigsbee B, Deck MDF, et al. Nonmetastatic superior sagittal sinus thrombosis complicating systemic cancer. Neurology 1979 ; 29 : 139-46.
19) 小林祥泰, 日野英忠, 他. 上矢状静脈洞血栓症を呈した先天性アンチトロンビンIII欠乏症の2家系. 臨床神経 1980 ; 20 : 904-10.
20) Lau SO, Bock GH, et al. Sagittal sinus thrombosis in the nephritic syndrome. J Pediatr 1980 ; 97 : 948-50.
21) Confavreux C, Brunet P, et al. Congenital protein C deficiency and superior sagittal sinus thrombosis causing isolated intracranial hypertension. J Neurol Neurosurg Psychiatry 1994 ; 57 : 655-7.
22) Cros D, Comp PC, et al. Superior sagittal sinus thrombosis in a patient with protein S deficiency. Stroke 1990 ; 21 : 633-6.
23) 武井和夫, 荒木信夫, 他. 眼窩深部の疼痛で発症した横静脈洞血栓症の1例. 日本頭痛学会誌 2002 ; 29 (1) ; 124-6.
24) Carhuapoma JR, Mitsias P, et al. Cerebral venous thrombosis and anticardiolipin antibodies. Stroke 1997 ; 28 : 2363-9.
25) Daif A, Awada A, et al. Cerebral venous thrombosis in adults. A study of 40 cases from Saudi Arabia. Stroke 1995 ; 26 : 1193-5.
26) Borda IT, Southern RF, et al. Cerebral venous thrombosis in ulcerative colitis. Gastroenterolgy 1973 ; 64 : 116-9.
27) 日本脳卒中学会 脳卒中ガイドライン委員会編. 脳静脈・静脈洞閉塞症. 脳卒中治療ガイドライン 2015, 協和企画, 東京, 2015.
28) Saposnik G, Barinagarrementeria F, et al. Diagnosis and management of cerebral venous thrombosis : a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2011 ; 42 : 1158-92.
29) Coutinho JM, Ferro JM, et al. Unfractionated or low-molecular weight heparin for the treatment of cerebral venous thrombosis. Stroke 2010 ; 41 : 2575-80.
30) Misra UK, Kalita J, et al. Low molecular weight heparin versus unfractionated heparin in cerebral venous sinus thrombosis : A randomized controlled trial. Eur J Neurol 2012 ; 19 : 1030-6.
31) Hon SF, Li HL, Cheng PW. Use of direct thrombin inhibitor for treatment of cerebral venous thrombosis. J Stroke Cerebrovasc Dis 2012 ; 21 : 915. e11-5.
32) Mohammadian R, Sohrabi B, et al. Treatment of progressive cerebral sinuses thrombosis with local thrombolysis. Interv Neuroradiol 2012 ; 18 : 89-96.
33) Stam J, Majoie Charles BLM, et al. Endovascular thrombectomy and thrombolysis for severe cerebral sinus thrombosis : a prospective study. Stroke 2008 ; 39 : 1487-90.
34) Dentali F, Squizzato A, et al. Safety of thrombolysis in cerebral venous thrombosis : a systematic review of the literature (Provisional abstract). Thromb Haemost 2010 ; 104 : 1055-62.
35) Einhaupl K, Stam H, et al. EFNS guideline on the treatment of cerebral venous and sinus thrombosis in adult patients. Eur J Neurol 2010 ; 17 : 1229-35.
36) Kwan J, Guenther A. Antiepileptic drugs for the primary and secondary prevention seizures after intracranial venous thrombosis. Cochrane Database Syst Rev 2006 ; CD005501.
37) Aguiar de Sousa D, Mestre T, et al. Cerebral venous thrombosis in Behcet's disease : a systematic review. J Neurol 2011 ; 258 : 719-27.
38) Saadoun D, Wechsler B, et al. Cerebral venous thrombosis in Behcet's disease. Arthritis Rheum 2009 ; 61 : 518-26.
P.221 掲載の参考文献
1) Roman GC, Tatemichi TK, Erkinjunti T, et al. Vascular dementia : diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology 1993 ; 43 : 250-60.
2) Babikian V, Ropper AH. Binswanger's disease : a review. Stroke 1987 ; 18 : 2-12.
3) Joutel A, Corpechot C, Ducros A, et al. Notch3 mutations in CADASIL, a hereditary adult-onset condition causing stroke and dementia. Nature 1996 ; 383 : 707-10.
4) Hachinski VC, Iliff LD, Zilhka E, et al. Cerebral blood flow in dementia. Arch Neurol 1975 ; 32 : 632-7.
5) Forette F, Seux ML, Staessen JA, et al. Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial. Lancet 1998 ; 352 : 1347-51.
6) Suribhatla S, Dennis MS, Potter JF. A study of statin use in the prevention of cognitive impairment of vascular origin in the UK. J Neurol Sci 2005 ; 229-30 : 147-50.
7) Wilkinson D, Doody R, Helme R, et al. Donepezil in vascular dementia : a randomized, placebo-controlled study. Neurology 2003 ; 61 : 479-86.
8) Erkinjuntti T, Kurz A, Gauthier S, et al. Efficacy of galantamine in probable vascular dementia and Alzheimer's disease combined with cerebrovascular disease : a randomised trial. Lancet 2002 ; 359 : 1283-90.
9) Moretti R, Torre P, Antonello RM,et al. Rivastigmine in subcortical vascular dementia : a randomized, controlled, open 12-month study in 208 patients. Am J Alzheimers Dis Other Demen 2003 ; 18 : 265-72.
10) Orgogozo JM, Rigaud AS, Stoffler A, et al. Efficacy and safety of memantine in patients with mild to moderate vascular dementia : a randomized, placebo-controlled trial (MMM 300). Stroke 2002 ; 33 : 1834-9.
P.231 掲載の参考文献
2) Camilo O, Goldstein LB. Seizures and epilepsy after ischemic stroke. Stroke 2004 ; 35 : 1769-75.
3) Bladin CF, Alexangrov AV, et al. Seizures after stroke. A prospective multicenter study. Arch Neurol 2000 ; 57 : 1617-22.
4) Beghi E, D'Alessandro R, et al. Incidence and predictors of acute symptomatic seizures after stroke. Neurology 2011 ; 77 : 1785-93.
5) Burn J, Dennis M, et al. Epileptic seizures after first stroke : the Oxfordshire Community Stroke Project. BMJ 1997 ; 315 : 1582-7.
6) Kim SY, Buckwalter M, et al. Blood-brain barrier dysfunction-induced inflammatory signaling in brain pathology and epileptogenesis. Epilepsia 2012 ; 53 (suppl 6) : 37-44.
7) Schoknecht K, Shalev H, et al. Blood-brain barrier dysfunction in brain disease : Clinical experience. Epilepsia 2012 ; 53 (suppl6) : 7-13.
8) Velioglu SK, Ozmenog M, et al. Status epilepticus after stroke. Stroke 2001 ; 32 : 1169-72.
9) De Reuck J, Van Maele G. Transient ischemic attacks and inhibitory seizures in elderly patients. Eur Neurol 2009 ; 62 : 344-8.
10) 日本脳卒中学会 脳卒中ガイドライン委員会編. 脳卒中ガイドライン 2015, 協和企画, 東京, 2015, p15, 125, 153.
P.239 掲載の参考文献
1) Vizcarra JA, et al. Vascular Parkinsonism : deconstructing a syndrome. Mov Disord 2015 ; 30 (7) : 886-94.
2) Korczyn AD. Vascular parkinsonism-characteristics, pathogenesis and treatment. Nat Rev Neurol 2015 ; 11 (6) : 319-26.
3) 高橋一司. 内科医のためのパーキンソン病診療. パーキンソン症候群の鑑別診断とその治療, 脳血管性パーキンソン症候群. 内科 2007 ; 99 (5) : 856-61.
5) 高橋裕秀, 篠原幸人. パーキンソン病と類縁疾患. パーキンソニズムを呈する疾患の診断と治療, 脳血管性パーキンソニズム. 日内会誌 (0021-5384) 2003 ; 1472-78.
6) Yamanouchi H, Nagura H. Neurological signs and frontal white matter lesions in vascular parkinsonism. A clinicopathologic study. Stroke 1997 ; 28 (5) : 965-9.
7) Zijlmans JC, et al. Clinicopathological investigation of vascular parkinsonism, including clinical criteria for diagnosis. Mov Disord 2004 ; 19 (6) : 630-40.
8) Zijlmans JC, et al. Quantitative gait analysis in patients with vascular parkinsonism. Mov Disord 1996 ; 11 (5) : 501-8.
9) Ueno E, Yanagisawa N, Takemi M. Gait disorders in parkinsonism : A study with floor reaction forces and EMG. In Narabayashi H, Nagatsu T, Yanagisawa N, et al editors : Advances in Neurology, Parkinson's Disease from Basic Research to Treatment. New York, Raven Press, 1993 ; 60 : p414-18.
10) 高橋一司. 運動系/姿勢・歩行 診察の方法. 神経診察クローズアップ改訂第2版 (鈴木則宏 編), メジカルビュー社, 東京, 2015, p123.
11) Abdo WF, et al. Ten steps to identify atypical parkinsonism. J Neurol Neurosurg Psychiatry 2006 ; 77 (12) : 1367-9.
12) Zijlmans JC, et al. MRI in patients with suspected vascular parkinsonism. Neurology 1995 ; 45 (12) : 2183-8.
13) Gerschlager, W, et al. [123I] beta-CIT SPECT distinguishes vascular parkinsonism from Parkinson's disease. Mov Disord 2002 ; 17 (3) : 518-23.
14) Lorberboym M, et al. 123I-FP-CIT SPECT imaging of dopamine transporters in patients with cerebrovascular disease and clinical diagnosis of vascular parkinsonism. J Nucl Med 2004 ; 45 (10) : 1688-93.
15) Postuma RB, et al. MDS clinical diagnostic criteria for Parkinson's disease. Mov Disord 2015 ; 30 (12) : 1591-601.
17) Katzenschlager R, et al. Olfactory function distinguishes vascular parkinsonism from Parkinson's disease. J Neurol Neurosurg Psychiatry 2004 ; 75 (12) : 1749-52.
18) 赫寛雄, 他. 脳血管性パーキンソニズムにおけるドパミンD2受容体結合能の検討. 臨床神経学 (0009-918X) 2001 ; 659-64.
19) Zijlmans JC, et al. The L-dopa response in vascular parkinsonism. J Neurol Neurosurg Psychiatry 2004 ; 75 (4) : 545-7.
20) Demirkiran M, Bozdemir H, Sarica Y. Vascular parkinsonism : a distinct, heterogeneous clinical entity. Acta Neurol Scand 2001 ; 104 (2) : 63-7.
21) Ondo WG, Chan LL, Levy JK. Vascular parkinsonism : clinical correlates predicting motor improvement after lumbar puncture. Mov Disord 2002 ; 17 (1) : 91-7.

IV 脳卒中の最近のトピックス

P.247 掲載の参考文献
1) 日本脳卒中学会 脳卒中ガイドライン作成委員会編. 脳卒中治療ガイドライン 2015, 協和企画, 東京, 2015.
P.253 掲載の参考文献
1) Cordonnier C, Al-Shahi Salman R, et al. Spontaneous brain microbleeds : Systematic review, subgroup analyses and standards for study design and reporting. Brain 2007 ; 130 : 1988-2003.
2) Bokura H, Saika R, et al. Microbleeds are associated with subsequent hemorrhagic and ischemic stroke in healthy elderly individuals. Stroke 2011 ; 42 : 1867-71.
3) Charidimou A, Shakeshaft C, et al. Cerebral microbleeds on magnetic resonance imaging and anticoagulant-associated intracerebral hemorrhage risk. Front Neurol 2012 ; 3 : 133.
4) Poels MM, Ikram MA, et al. Cerebral microbleeds are associated with worse cognitive function : The Rotterdam scan study. Neurology 2012 ; 78 : 326-33.
5) Akoudad S, Wolters FJ, et al. Association of cerebral microbleeds with cognitive decline and dementia. JAMA Neurol 2016 ; 73 : 934-43.
P.259 掲載の参考文献
1) Pantoni L. Cerebral small vessel disease : from pathogenesis and clinical characteristics to therapeutic challenges. Lancet Neurol 2010 ; 9 : 689-701.
2) Bokura H, Saika R, Yamaguchi T, et al. Yamaguchi Microbleeds are associated with subsequent hemorrhagic and ischemic stroke in healthy elderly individuals. Stroke 2011 ; 42 : 1867-71.
3) Vermeer SE, Prins ND, den Heijer T, et al. Silent brain infarcts and the risk of dementia and cognitive decline. N Engl J Med 2003 ; 348 : 1215-22.
4) Debette S, Markus HS. The clinical importance of white matter hyperintensities on brain magnetic resonance imaging : systematic review and meta-analysis. BMJ 2010 ; 341 : c3666.
5) Miwa K, Tanaka M, Okazaki S, et al. Multiple or mixed cerebral microbleeds and dementia in patients with vascular risk factors. Neurology 2014 ; 83 : 646-53.
6) Emerging Risk Factors Collaboration, Kaptoge S, Di Angelantonio E, Lowe G, et al. C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality : an individual participant meta-analysis. Lancet 2010 ; 375 : 132-40.
P.263 掲載の参考文献
1) Unruptured intracranial aneurysms-rusk of rupture and risks of surgical intervention : International Study of Unruptured Intracranial Aneurysms Investigators. N Engl J Med 1998 ; 339 : 1725-33.
2) Morita A, Kirino T, et al. The natural course of unruptured cerebral aneurysms in a Japanese cohort. N Engl J Med 2012 ; 366 : 2472-82.
3) 青木友浩. 血流と脳動脈瘤形成. 細胞 2011 ; 43 : 326-9.
4) 吉田和道. 嚢状動脈瘤の成因と破裂機序. 脳出血・くも膜下出血診療読本, 中外医学社, 東京, 2016, 229-39.
5) Hasan DM, Mahaney KB, et al. International Study of Unruptured Intracranial Aneurysms Investigators : Aspirin as a promising agent for decreasing incidence of cerebral aneurysm rupture. Stroke 2011 ; 42 : 3156-62.
6) Hasan DM, Chalouhi N, et al. Evidence that acetylsalicylic acid attenuates inflammation in the walls of human cerebral aneurysm : preliminary results. J Am Heart Asso 2013 ; 22 : e000019.
7) Hasan DM, Chalouhi N, et al. Early change in ferumoxytolenhanced magnetic resonance imaging signal suggests unstable human cerebral aneurysm : A pilot study. Stroke 2012 ; 43 : 3258-65.
8) 大石英則, 新井一. 治療戦略と戦術を中心とした症例報告 フローダイバーターを用いて血管内治療を行った部分血栓化大型脳動脈瘤の1例 (解説). 脳外誌 2016 ; 25 : 454-60.

V 社会資源の活用法

P.274 掲載の参考文献
1) 厚生労働省老健局総務課. 公的介護保険制度の現状と今後の役割, 平成27年度. http://www.mhlw.go.jp/file/06-Seisakujouhou-12300000-Roukenkyoku/201602kaigohokenntoha_2.pdf
2) 厚労省HP. 特定疾病の選定基準の考え方. http://www.mhlw.go.jp/topics/kaigo/nintei/gaiyo3.html
3) http://www.mhlw.go.jp/bunya/shougaihoken/other/dl/140121_04.pdf#search= '厚生労働省+介護保険意見書記入例'
4) http://www.fukushihoken.metro.tokyo.jp/shinsho/shinshou_techou/shiteiikoushuukai.files/shitaifujiyuhen.pdf#search='進呈障害者肢体不自由手帳記入例'
5) http://www.pref.osaka.lg.jp/attach/1192/00000000/kaigonotekiyou240330.pdf#search= '厚生労働省は, 2007+年+3+月に「障害者自立支援法に基づく自立支援給付と介護保険制度との適用関係等について」を通知して, 「介護保険優先原則」を基本'
P.283 掲載の参考文献
1) 厚生労働省老健局総務課. 公的介護保険制度の現状と今後の役割, 平成27年度. http://www.mhlw.go.jp/file/06-Seisakujouhou-12300000-Roukenkyoku/201602kaigohokenntoha_2.pdf
2) 厚労省HP. 特定疾病の選定基準の考え方. http://www.mhlw.go.jp/topics/kaigo/nintei/gaiyo3.html
3) http://www.mhlw.go.jp/bunya/shougaihoken/other/dl/140121_04.pdf#search= '厚生労働省+介護保険意見書記入例'
4) http://www.fukushihoken.metro.tokyo.jp/shinsho/shinshou_techou/shiteiikoushuukai.files/shitaifujiyuhen.pdf#search='進呈障害者肢体不自由手帳記入例'
5) http://www.pref.osaka.lg.jp/attach/1192/00000000/kaigonotekiyou240330.pdf#search= '厚生労働省は, 2007+年+3+月に「障害者自立支援法に基づく自立支援給付と介護保険制度との適用関係等について」を通知して, 「介護保険優先原則」を基本'

VI Case study

P.291 掲載の参考文献
1) 日本脳卒中学会 脳卒中ガイドライン委員会編. 脳卒中治療ガイドライン 2015, 協和企画, 東京, 2015.
2) Kwon SU, Cho YJ, et al. Cilostazol prevents the progression of the symptomatic intracranial arterial stenosis : the multicenter double-blind placebo-controlled trial of cilostazol in symptomatic intracranial arterial stenosis. Stroke 2005 ; 36 : 782-6.
3) Jauch EC, Saver JL, et al. Guidelines for the early management of patients with acute ischemic stroke : a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2013 ; 44 : 870-947.
4) Derdeyn CP, Chimowitz MI, et al. Aggressive medical treatment with or without stenting in high-risk patients with intracranial artery stenosis (SAMMPRIS) : the final results of a randomised trial. Lancet 2014 ; 383 : 333-41.
P.295 掲載の参考文献
1) 日本脳卒中学会 脳卒中ガイドライン委員会編. 脳卒中治療ガイドライン 2015, 協和企画, 東京, 2015.
2) 日本脳卒中学会脳卒中医療向上・社会保険委員会 rt-PA (アルテプラーゼ) 静注療法指針改訂部会. rt-PA (アルテプラーゼ) 静注療法適正治療指針第二版. 脳卒中 2012 ; 34 : 443-80. (http://www.jsts.gr.jp/img/rt-PA02.pdf)
3) Minematsu K, Toyoda K, et al. Guidelines for the intravenous application of recombinant tissue-type plasminogen activator (alteplase), the second edition, October 2012 : a guideline from the Japan Stroke Society. J Stroke Cerebrovasc Dis 2013 ; 22 : 571-600.
4) 日本脳卒中学会, 日本脳神経外科学会, 日本脳神経血管内治療学会. 経皮経管的脳血栓回収用機器適正使用指針第2版. (http://www.jsts.gr.jp/img/noukessen.pdf)
5) 循環器病の診断と治療に関するガイドライン (2012年度合同研究班報告). 心房細動治療 (薬物) ガイドライン (2013年改訂版). (http://www.j-circ.or.jp/guideline/pdf/JCS2013_inoue_h.pdf)
P.301 掲載の参考文献
1) Ogasawara K, Sakai N, Kuroiwa T, et al ; Japanese Society for Treatment at Neck in Cerebrovascular Disease Study Group. Intracranial hemorrhage associated with cerebral hyperperfusion syndrome following carotid endarterectomy and carotid artery stenting : retrospective review of 4494 patients. J Neurosurg 2007 ; 107 (6) : 1130-6.
2) Groschel K, Riecker A, Schulz JB, et al. Systematic review of early recurrent stenosis after carotid angioplasty and stenting. Stroke 2005 ; 36 (2) : 367-73.
3) Setacci C, Chisci E, Setacci F, et al. Grading carotid intrastent restenosis : a 6-year follow-up study. Stroke 2008 ; 39 (4) : 1189-96.
4) Diener HC, Bogousslavsky J, Brass LM, et al ; MATCH investigators. Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH) : randomised, double-blind, placebo-controlled trial. Lancet 2004 ; 364 (9431) : 331-7.

最近チェックした商品履歴

Loading...